Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)
CNY 23.97
(0.42%)
CNY 23.97
(0.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 959.61 Million CNY | -33.3% |
| 2022 | 1.43 Billion CNY | 77.03% |
| 2021 | 812.72 Million CNY | -11.65% |
| 2020 | 919.89 Million CNY | 41.42% |
| 2019 | 650.48 Million CNY | 13.19% |
| 2018 | 574.67 Million CNY | 18.98% |
| 2017 | 482.98 Million CNY | 0.65% |
| 2016 | 479.87 Million CNY | -8.3% |
| 2015 | 523.31 Million CNY | 7.48% |
| 2014 | 486.88 Million CNY | 5.57% |
| 2013 | 461.21 Million CNY | 12.61% |
| 2012 | 409.56 Million CNY | 21.28% |
| 2011 | 337.69 Million CNY | 4.98% |
| 2010 | 321.68 Million CNY | -16.25% |
| 2009 | 384.1 Million CNY | 31.79% |
| 2008 | 291.46 Million CNY | 22.19% |
| 2007 | 238.53 Million CNY | -4.79% |
| 2006 | 250.53 Million CNY | 42.79% |
| 2005 | 175.45 Million CNY | 34.2% |
| 2004 | 130.74 Million CNY | -4.29% |
| 2003 | 136.6 Million CNY | -13.86% |
| 2002 | 158.58 Million CNY | 6.52% |
| 2001 | 148.87 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 994.3 Million CNY | -15.77% |
| 2024 Q2 | 1.18 Billion CNY | 21.86% |
| 2024 Q1 | 968.72 Million CNY | 0.95% |
| 2023 FY | 959.61 Million CNY | -33.3% |
| 2023 Q1 | 1.28 Billion CNY | -10.57% |
| 2023 Q4 | 959.61 Million CNY | -17.7% |
| 2023 Q2 | 1.39 Billion CNY | 8.2% |
| 2023 Q3 | 1.16 Billion CNY | -16.24% |
| 2022 Q1 | 834.79 Million CNY | 2.72% |
| 2022 FY | 1.43 Billion CNY | 77.03% |
| 2022 Q4 | 1.43 Billion CNY | 7.48% |
| 2022 Q3 | 1.33 Billion CNY | 47.61% |
| 2022 Q2 | 906.85 Million CNY | 8.63% |
| 2021 Q2 | 920.02 Million CNY | -1.81% |
| 2021 Q1 | 937.02 Million CNY | 1.86% |
| 2021 FY | 812.72 Million CNY | -11.65% |
| 2021 Q3 | 903.62 Million CNY | -1.78% |
| 2021 Q4 | 812.72 Million CNY | -10.06% |
| 2020 Q1 | 704.86 Million CNY | 8.36% |
| 2020 Q3 | 958.34 Million CNY | 19.74% |
| 2020 FY | 919.89 Million CNY | 41.42% |
| 2020 Q2 | 800.35 Million CNY | 13.55% |
| 2020 Q4 | 919.89 Million CNY | -4.01% |
| 2019 Q2 | 685.06 Million CNY | 23.47% |
| 2019 FY | 650.48 Million CNY | 13.19% |
| 2019 Q4 | 650.48 Million CNY | -10.89% |
| 2019 Q3 | 729.99 Million CNY | 6.56% |
| 2019 Q1 | 554.86 Million CNY | -3.45% |
| 2018 Q2 | 527.17 Million CNY | 14.76% |
| 2018 FY | 574.67 Million CNY | 18.98% |
| 2018 Q1 | 459.35 Million CNY | -4.89% |
| 2018 Q3 | 549.62 Million CNY | 4.26% |
| 2018 Q4 | 574.67 Million CNY | 4.56% |
| 2017 FY | 482.98 Million CNY | 0.65% |
| 2017 Q2 | 437.81 Million CNY | 24.26% |
| 2017 Q3 | 439.93 Million CNY | 0.48% |
| 2017 Q4 | 482.98 Million CNY | 9.79% |
| 2017 Q1 | 352.34 Million CNY | -26.58% |
| 2016 Q2 | 590.33 Million CNY | 18.09% |
| 2016 Q3 | 545.11 Million CNY | -7.66% |
| 2016 FY | 479.87 Million CNY | -8.3% |
| 2016 Q1 | 499.88 Million CNY | -4.48% |
| 2016 Q4 | 479.87 Million CNY | -11.97% |
| 2015 Q4 | 523.31 Million CNY | 21.33% |
| 2015 FY | 523.31 Million CNY | 7.48% |
| 2015 Q2 | 437.44 Million CNY | -8.56% |
| 2015 Q1 | 478.39 Million CNY | -1.74% |
| 2015 Q3 | 431.31 Million CNY | -1.4% |
| 2014 FY | 486.88 Million CNY | 5.57% |
| 2014 Q4 | 486.88 Million CNY | -5.39% |
| 2014 Q3 | 514.6 Million CNY | 9.63% |
| 2014 Q2 | 469.39 Million CNY | 1.6% |
| 2014 Q1 | 462.01 Million CNY | 0.17% |
| 2013 Q4 | 461.21 Million CNY | -8.11% |
| 2013 Q1 | 559.33 Million CNY | 36.57% |
| 2013 Q2 | 487.93 Million CNY | -12.76% |
| 2013 Q3 | 501.89 Million CNY | 2.86% |
| 2013 FY | 461.21 Million CNY | 12.61% |
| 2012 Q2 | 607.09 Million CNY | 53.55% |
| 2012 Q1 | 395.36 Million CNY | 17.08% |
| 2012 Q3 | 610.35 Million CNY | 0.54% |
| 2012 Q4 | 409.56 Million CNY | -32.9% |
| 2012 FY | 409.56 Million CNY | 21.28% |
| 2011 Q4 | 337.69 Million CNY | 3.76% |
| 2011 Q1 | 317.08 Million CNY | -1.43% |
| 2011 Q2 | 285.15 Million CNY | -10.07% |
| 2011 FY | 337.69 Million CNY | 4.98% |
| 2011 Q3 | 325.45 Million CNY | 14.13% |
| 2010 Q3 | 370.35 Million CNY | 1.09% |
| 2010 FY | 321.68 Million CNY | -16.25% |
| 2010 Q2 | 366.34 Million CNY | -5.07% |
| 2010 Q1 | 385.9 Million CNY | 0.47% |
| 2010 Q4 | 321.68 Million CNY | -13.14% |
| 2009 Q4 | 384.1 Million CNY | -17.1% |
| 2009 FY | 384.1 Million CNY | 31.79% |
| 2009 Q3 | 463.31 Million CNY | -38.07% |
| 2009 Q2 | 748.12 Million CNY | 19.17% |
| 2009 Q1 | 627.75 Million CNY | 115.38% |
| 2008 Q4 | 291.46 Million CNY | 5.0% |
| 2008 Q2 | 195.36 Million CNY | -3.9% |
| 2008 Q1 | 203.28 Million CNY | -14.78% |
| 2008 Q3 | 277.57 Million CNY | 42.08% |
| 2008 FY | 291.46 Million CNY | 22.19% |
| 2007 Q3 | 225.8 Million CNY | 7.98% |
| 2007 Q2 | 209.11 Million CNY | 9.69% |
| 2007 FY | 238.53 Million CNY | -4.79% |
| 2007 Q1 | 190.63 Million CNY | -23.91% |
| 2007 Q4 | 238.53 Million CNY | 5.64% |
| 2006 Q3 | 192.76 Million CNY | -22.64% |
| 2006 Q4 | 250.53 Million CNY | 29.97% |
| 2006 FY | 250.53 Million CNY | 42.79% |
| 2006 Q2 | 249.18 Million CNY | 26.69% |
| 2006 Q1 | 196.68 Million CNY | 12.1% |
| 2005 Q1 | 120.98 Million CNY | -7.47% |
| 2005 Q3 | 141.19 Million CNY | -15.4% |
| 2005 FY | 175.45 Million CNY | 34.2% |
| 2005 Q2 | 166.89 Million CNY | 37.95% |
| 2005 Q4 | 175.45 Million CNY | 24.26% |
| 2004 FY | 130.74 Million CNY | -4.29% |
| 2004 Q3 | 109.38 Million CNY | -12.59% |
| 2004 Q2 | 125.14 Million CNY | 0.0% |
| 2004 Q4 | 130.74 Million CNY | 19.52% |
| 2003 Q4 | 136.6 Million CNY | 0.0% |
| 2003 FY | 136.6 Million CNY | -13.86% |
| 2002 FY | 158.58 Million CNY | 6.52% |
| 2001 FY | 148.87 Million CNY | 0.0% |